Inspire Medical Systems (INSP) closed at $62.31 on November 10, 2026, down 3.1% from the previous close, on volume of 374,989 shares (30-day average 824,853).
Data as of November 10, 2026.
10-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 2, 2026 | Call Spread | 20-Nov-2670 : 80 C | 304 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
Inspire Medical Systems, Inc. to Present at the Stifel 2026 Healthcare Conference
Globe Newswire (Tue, 3-Nov 4:05 PM ET)
Inspire Medical Systems, Inc. Announces Third Quarter 2026 Financial Results
Globe Newswire (Mon, 2-Nov 4:28 PM ET)
Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer
Business Wire (Mon, 12-Oct 4:05 PM ET)
Globe Newswire (Fri, 9-Oct 11:55 AM ET)
Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
Globe Newswire (Mon, 5-Oct 4:05 PM ET)
Globe Newswire (Thu, 1-Oct 4:03 PM ET)
Globe Newswire (Thu, 27-Aug 10:15 AM ET)
Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
Globe Newswire (Wed, 26-Aug 9:15 AM ET)
Addition of Dr. Myriam Curet to Mobia Medical Board Highlights Surge in Clinical Leadership
Market Chameleon (Tue, 4-Aug 4:04 AM ET)
Rosen Law Urges Inspire Medical Investors to Act Ahead of Key Class Action Deadline
Market Chameleon (Tue, 25-Nov 6:08 AM ET)
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
Inspire Medical Systems trades on the NYSE stock market under the symbol INSP.
As of November 10, 2026, INSP stock price declined to $62.31 with 374,989 million shares trading.
INSP has a beta of 1.51, meaning it tends to be more sensitive to market movements. INSP has a correlation of 0.07 to the broad based SPY ETF.
INSP has a market cap of $1.79 billion. This is considered a Small Cap stock.
Last quarter Inspire Medical Systems reported $207 million in Revenue and $.14 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.05.
In the last 3 years, INSP traded as high as $257.40 and as low as $38.91.
The top ETF exchange traded funds that INSP belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.
INSP has underperformed the market in the last year with a price return of -23.8% while the SPY ETF gained +12.9%. However, in the short term, INSP had mixed performance relative to the market. It has outperformed in the last 3 months, returning +3.6% vs -2.8% return in SPY. But in the last 2 weeks, INSP shares have been beat by the market, returning -12.3% compared to an SPY return of -2.0%.
INSP support price is $62.60 and resistance is $66.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INSP shares will trade within this expected range on the day.
